RankingsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Financials
  4. Cost of revenue

Edwards Lifesciences CorpEW

Market cap
$49.9B
P/E ratio
SummaryFinancials
Period EndCost of revenue (Million USD)YoY (%)
Dec 31, 20241,118-19.01%
Dec 31, 20231,380+27.71%
Dec 31, 20221,080-13.49%
Dec 31, 20211,249+15.57%
Dec 31, 20201,081-3.03%
Dec 31, 20191,114+18.63%
Dec 31, 2018939+7.32%
Dec 31, 2017875+9.77%
Dec 31, 2016797+29.20%
Dec 31, 2015617-1.34%
Dec 31, 2014626+19.75%
Dec 31, 2013522+5.62%
Dec 31, 2012495+0.98%
Dec 31, 2011490+19.96%
Dec 31, 2010408

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)